rs326217
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001376571.1(MADD):āc.1440T>Cā(p.Asn480Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.297 in 1,609,658 control chromosomes in the GnomAD database, including 71,885 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.29 ( 6496 hom., cov: 32)
Exomes š: 0.30 ( 65389 hom. )
Consequence
MADD
NM_001376571.1 synonymous
NM_001376571.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0140
Genes affected
MADD (HGNC:6766): (MAP kinase activating death domain) Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells by cytoplasmic adaptor proteins. The protein encoded by this gene is a death domain-containing adaptor protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activated protein kinase (MAPK) and propagate the apoptotic signal. It is membrane-bound and expressed at a higher level in neoplastic cells than in normal cells. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 11-47281724-T-C is Benign according to our data. Variant chr11-47281724-T-C is described in ClinVar as [Benign]. Clinvar id is 1321156.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.014 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MADD | NM_001376571.1 | c.1440T>C | p.Asn480Asn | synonymous_variant | 8/37 | NP_001363500.1 | ||
MADD | NM_003682.4 | c.1440T>C | p.Asn480Asn | synonymous_variant | 8/36 | NP_003673.3 | ||
MADD | NM_001376572.1 | c.1440T>C | p.Asn480Asn | synonymous_variant | 8/37 | NP_001363501.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MADD | ENST00000706887.1 | c.1440T>C | p.Asn480Asn | synonymous_variant | 8/37 | ENSP00000516604.1 |
Frequencies
GnomAD3 genomes AF: 0.291 AC: 44159AN: 151906Hom.: 6476 Cov.: 32
GnomAD3 genomes
AF:
AC:
44159
AN:
151906
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.303 AC: 75931AN: 250342Hom.: 11848 AF XY: 0.302 AC XY: 40896AN XY: 135322
GnomAD3 exomes
AF:
AC:
75931
AN:
250342
Hom.:
AF XY:
AC XY:
40896
AN XY:
135322
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.297 AC: 433406AN: 1457634Hom.: 65389 Cov.: 34 AF XY: 0.297 AC XY: 215449AN XY: 724876
GnomAD4 exome
AF:
AC:
433406
AN:
1457634
Hom.:
Cov.:
34
AF XY:
AC XY:
215449
AN XY:
724876
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.291 AC: 44224AN: 152024Hom.: 6496 Cov.: 32 AF XY: 0.290 AC XY: 21569AN XY: 74318
GnomAD4 genome
AF:
AC:
44224
AN:
152024
Hom.:
Cov.:
32
AF XY:
AC XY:
21569
AN XY:
74318
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1121
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Deeah syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at